Preparation and characterisation of lornoxicam solid dispersion systems using hot melt extrusion technique

Journal of Pharmaceutical Investigation

Volumn 44, Issue 1, 2014, Pages 41-59

  Fule, Ritesh ^a   Meer, Tarique ^a   Amin, Purnima ^a   Dhamecha, Dinesh ^b   Ghadlinge, Shyam ^c  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b KLE UNIVERSITY   (India)

^c Alkem Laboratories Ltd   (India)

Author keywords

Dissolution rate; Hot melt extrusion; Lornoxicam; Raman spectroscopy; Solid dispersion; Solubility enhancement

Indexed keywords

3,5 DIHYDROXY BENZOIC ACID; BENZOIC ACID DERIVATIVE; CIPROFLOXACIN; HYPERBRANCHED POLYESTER; POLYESTER; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONJUGATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; ESTERIFICATION; IN VITRO STUDY; MICROSCOPY; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; VISCOSITY;

EID: 84893382757     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0099-7     Document Type: Article

References (34)

1. Almeida A, Saerens L, De Beer T, Remon JP, Vervaet C (2012) Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Int J Pharm 439: 223-229. doi: 10. 1016/j. ijpharm. 2012. 09. 037.
2. Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG (2008) Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech 9: 563-570.
3. Bramhane DM, Saindane NS, Vavia PR (2011) Inclusion complexation of weakly acidic NSAID with β-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component. J Incl Phenom Macrocycl Chem 69: 453-460.
4. Breitenbach J (2002) Melt extrusion: from process to drug delivery technology. Eu J Pharm Biopharm 54: 107-117.
5. Burugu R (2011) Stability-indicating LC method for analysis of lornoxicam in the finished dosage form. Int J Pharm Pharm Sci 3: 318-322.
6. Chemete SZ (2012) A factorial study on enhancement of solubility and dissolution rate of lornoxicam employing Hp-β-cyclodextrin and surfactants. Int J Pharm Sci Res 3(7): 2252-2256.
7. Chokshi RJ, Malick WA (2007) Improving the dissolution rate of poorly water soluble drug by SD and solid solution. Drug Deliv 14(1): 33-45.
8. Forster A, Hempenstall J, Tucker I, Rades T (2001) Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 226: 147-161.
9. Fu J, Zhang L (2010) Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Technol 204: 214-221.
10. Fule RA, Amin PD (2013a) Artemether-soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristics. J Pharm 1: 1-15.
11. Fule RA, Amin PD (2013b) Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation. J Pharm Inv 43: 305-321.
12. Gavin PA, Osama AD (2010) Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharm 62: 1580-1590.
13. Greenhalgh DJ, Timmins PY (1999) Solubility parameters as predictors of miscibility in SD. J Pharm Sci 88: 1182-1190.
14. Higuchi T, Connors K (1965) Phase-solubility techniques. Adv Anal Chem Instrum Tech 4: 117-130.
15. Jung JY (1999) Enhanced solubility and dissolution rate of itraconazole by a SD technique. Int J Pharm 187: 209-218.
16. Kalogeras IM (2011) A novel approach for analysing glass-transition temperature vs. composition patterns: application to pharmaceutical compound + polymer systems. Eur J Pharm Sci 42: 470-483.
17. Kharwade M (2012) Solubility behavior of lornoxicam in binary solvents of pharmaceutical interest. J Sol Chem 41(8): 1364-1374.
18. Konno H, Taylor LS (2006) Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 95: 2692-2705.
19. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using SD. Eur J Pharm Biopharm 50: 47-60.
20. Linn M (2012) Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro. Eu J Pharm Sci 45: 336-343.
21. Maniruzzaman M, Morgan DJ, Douroumis D (2013) Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 443: 199-208.
22. Modi A (2006) Enhancement of dissolution profile by solid dispersion (Kneading) technique. AAPS PharmSciTech 7(3): 1-6.
23. Osama AA, David SJ (2012) Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods. J Pharm Sci 101: 200-213.
24. Pan RN (2000) Enhancement of dissolution and bioavailability of Piroxicam in solid dispersion system. Drug Dev Ind Pharm 26(9): 989-994.
25. Prajapati P (2012) Azeotropic mixture used for development and validation of lornoxicam in bulk and its tablet dosage form by spectrophotometric method. J Pharm Anal 2: 306-309.
26. Saerens L, Dierickx L, Lenain B (2011) Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. Eur J Pharm Biopharm 77: 158-163.
27. Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Jayachandra BR (2012) Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement. J Pharm Sci 101: 3456-3464.
28. Serajuddin Abu TM (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharma Sci 88: 1058-1066.
29. Singla K (2012) Preparation and evaluation of lornoxicam niosomal gel. Int Res J Pharm 3(4): 378-383.
30. Vasconcelos T, Sarmento B (2007) SD as strategy to improve oral bioavailability of poorly water soluble drugs. Drug Discov Today 12: 1068-1075.
31. Xie Y (2009) Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L. AAPS PharmSciTech 10(2): 631-640.
32. Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG (2012) Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm 422: 202-210.
33. Yang J, Gray K, Doney J (2010) An improved kinetics approach to describe the physical stability of amorphous SD. Int J Pharm 384: 24-31.
34. Zsombor KN, Attila B (2012) Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci 101: 322-332. doi: 10. 1002/jps. 22731.